Amarin | AMRN - DEBITO





DEBITO Cambiamento Data
AbbVie USD 72.86B 5.36B 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
AstraZeneca USD 32.24B 1.68B 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
DBV Technologies USD 6.1M 2.49M 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Novartis USD 49.01B 2.02B 2026-06